about
Neutrophil activation status in stable coronary artery disease.Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization StudyPatients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjectsC-reactive protein levels in the brugada syndrome.Associations between statins and COPD: a systematic review.Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?The metabolic syndromeShort duration of sleep is associated with elevated high-sensitivity C-reactive protein level in Taiwanese adults: a cross-sectional study.Association of sex hormones and C-reactive protein levels in menSeropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey.Effectiveness, safety and cost of drug substitution in hypertensionNovel 2,5-disubstituted-1,3,4-oxadiazoles as anti-inflammatory drugs.Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials.Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey.C-reactive protein and long-term ischemic stroke prognosis.Atherosclerosis in systemic lupus erythematosus.Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled TrialFatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors.Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome.Interval training based on ventilatory anaerobic threshold increases cardiac vagal modulation and decreases high-sensitivity c-reative protein: randomized clinical trial in coronary artery disease.Oxidative Stress and IgG Antibody Modify Periodontitis-CRP AssociationCorrelates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.Inflammation and exercise (INFLAME): study rationale, design, and methods.Understanding proteomics.Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery DiseaseC-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polypsEvaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patientsDietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL studyLong-term variability of inflammatory markers and associated factors in a population-based cohort.Lower extremity vein graft failure: a translational approach.Update in chronic obstructive pulmonary disease 2007.Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors.Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women.Pleiotropic effects and cholesterol-lowering therapy.
P2860
Q28469325-3883980E-76F9-443E-9EE8-93BF018418D9Q28600936-5CC4691B-657E-49EB-9BFA-E079F94989D5Q30318873-EB7B0583-FB3F-4CE5-8F67-6F54E448167AQ33160813-229AB61B-7698-426F-80A7-12A893D072E0Q33481269-25EB1B54-EB97-412E-94DD-E320A4013770Q33528966-493DF6E1-CDAC-473A-AFD4-E5BB10EB0609Q33569142-D4556B49-A475-48ED-93B8-499FBBDEA521Q33793996-C0BA16B5-A1F7-474E-AB54-E94BDC3591D9Q33835277-B0A0A69F-95E8-43FE-B898-9565DEB3BEC8Q33838430-1AB98732-DC78-4550-924C-A0B8F8F10DBCQ33882623-6BFBB59C-D7FE-4D51-8225-2845E3E8B768Q34174844-CAC82687-2511-4586-ADD4-E22ADF902DC3Q34247656-2CC02066-08A0-4943-8C15-5A97A873E61AQ34290335-4C926C17-A5F6-45F9-BB2E-EF9D08C42B2EQ34362340-7613F874-03EA-4B3A-B6D7-5616CB61D242Q35046651-E8BC0A43-4AC0-43CE-8C14-8FBA45A89969Q35062696-886E0493-0B54-4E61-A1CD-1E42810C5FD4Q35379531-E3C5B5FD-4488-4F0A-BF62-5CCF2D874940Q35525108-0F307C4C-F064-42DF-93C1-C53AA34F4C27Q35815855-7B57ACA5-DFEC-402C-B58B-67C2DE307B60Q35925247-6C291AC3-EB0F-422F-A6CB-C311A64B05ABQ35930163-E605C15E-3271-469D-A7A1-FB630F2D8193Q36065338-5B339877-8772-4045-A704-BD86417388A1Q36309834-F382817B-8792-46D8-9D8B-4E4120FAAB21Q36343211-09C3F287-6775-4C8D-971C-29D2348A76FFQ36377673-B5626452-E8E7-4999-BE13-28A6C3F38845Q36469182-AEC2BBAC-776B-4387-8768-31F5CF8A1131Q36550992-D31AAE88-E778-4493-BDB5-C33A275D46F4Q36732620-0F2373F9-835D-400A-A1D6-266FF6A2D97CQ36735737-51AEAF34-316F-4928-95B6-ABF5719F18E7Q36922192-11BD64CF-89F2-402A-83EE-94FA7F36F287Q36950564-C2942B46-2BC4-4E77-BEBF-59FEC9055C24Q37063378-DE0D2DC2-14EF-47D1-BAF7-F2460095EA8CQ37095276-673DA6D8-3707-4BBB-A555-B9D7B7D9017AQ37096276-EB3E7386-FAB3-4213-B82B-F6BF6DF59E67Q37121388-9E1FB7C8-653F-4B2F-A588-49D37A140134Q37129292-86BE87C7-95E2-4969-B2D7-C07B41B04FDEQ37169687-CF91A40A-E68A-4462-AA85-37D8BB09C528Q37169720-525547B7-D5C3-416E-A085-E34E27764381Q37199617-ED6B4254-AC3E-41FC-B448-A6D5E18CAD8E
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
C-reactive protein (CRP)-lowering agents
@ast
C-reactive protein (CRP)-lowering agents
@en
C-reactive protein (CRP)-lowering agents
@nl
type
label
C-reactive protein (CRP)-lowering agents
@ast
C-reactive protein (CRP)-lowering agents
@en
C-reactive protein (CRP)-lowering agents
@nl
prefLabel
C-reactive protein (CRP)-lowering agents
@ast
C-reactive protein (CRP)-lowering agents
@en
C-reactive protein (CRP)-lowering agents
@nl
P2860
P3181
P1476
C-reactive protein (CRP)-lowering agents
@en
P2093
Kailash Prasad
P2860
P3181
P356
10.1111/J.1527-3466.2006.00033.X
P407
P577
2006-01-01T00:00:00Z